Esbriet 267 mg film-coated tablets, Ofev 150 mg soft capsules clinical trials

Pragmatic management of progressive disease in idiopathic pulmonary fibrosis: a randomized trial. PROGRESSION-IPF

This study looks at how well different medicines treat Idiopathic Pulmonary Fibrosis (IPF). It compares two common drugs, Esbriet and Ofev, to see which helps slow down the disease’s progress and if people can take them easily. It aims to find the best ways to manage IPF.